Health Insurance Literacy Intervention for Cancer Survivors

(CHAT-S Trial)

Age: 18 - 65

Sex: Any

Trial Phase: Academic

Sponsor: University of Utah

Disqualifiers: Developmental delay, Non-English speakers, others

Compensation: Varies

Number of Visits: 4

300 Participants Needed

Trial Summary

Will I have to stop taking my current medications?

The trial information does not specify whether you need to stop taking your current medications.

What data supports the effectiveness of the treatment CHAT-S for cancer survivors?

The research highlights that many cancer survivors have low health literacy, which can make managing their health and navigating the healthcare system difficult. Effective interventions, like CHAT-S, are needed to improve health literacy and ensure better care for these individuals. ^{1 2 3 4 5}

How is the CHAT-S treatment different from other treatments for cancer survivors?

CHAT-S is unique because it focuses on improving health insurance literacy among cancer survivors, helping them better navigate the healthcare system and potentially reduce financial hardships, unlike traditional treatments that focus solely on medical care. ^{1 4 6 7 8}

What is the purpose of this trial?

We will conduct a randomized controlled trial to test a 4-session virtual health insurance navigation intervention that will increase knowledge about health insurance, reduce financial burden, and improve surveillance for recurrence among 300 young adult cancer survivors ages 26 to 39. We will combine self-reported survey data with electronic health records and claims data to examine the trial outcomes and efficacy. We will also conduct an economic evaluation using cost-effectiveness and budget impact analyses, to establish the sustainability of the intervention at improving outcomes of young adult survivors through increasing their health insurance knowledge and decreasing their financial burden.

Eligibility Criteria

This trial is for young adult cancer survivors aged 26 to 45, who have been treated for breast, testicular, lymphoma, sarcoma, or colorectal cancer within the last year. Participants must speak English and be patients at specific Utah healthcare institutions.

Inclusion Criteria

I finished my initial cancer treatment less than a year ago.

I have been diagnosed with breast, testicular, lymphoma, sarcoma, or colorectal cancer.

Participants who are patients at the University of Utah/Huntsman Cancer Institute or Intermountain Healthcare

Exclusion Criteria

Participants unable to participate due to developmental delay

I speak a language other than English.

I cannot join via phone or video on a computer or mobile device.

Timeline

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Intervention

Participants undergo a 4-session virtual health insurance navigation intervention to improve health insurance literacy and reduce financial burden

8 weeks

4 virtual sessions

Follow-up

Participants are monitored for improvements in health insurance literacy, financial toxicity, and surveillance care for recurrence

18 months

Treatment Details

Interventions

• CHAT-S
• Usual Care

Trial Overview The study tests a virtual health insurance navigation program called CHAT-S against usual care. It aims to improve insurance knowledge, reduce financial stress and enhance monitoring for cancer recurrence in participants through four sessions.

Participant Groups

Group I: CHAT-S Experimental Treatment 1 Intervention

CHAT-S consists of 4 bi-weekly 35-45 minute videoconferencing sessions with a patient navigator and a patient booklet on insurance, costs, and survivorship care.

Group II: Usual Care Placebo Group 1 Intervention

Usual care will consist of a resource list sent by the navigator.

Who Is Running the Clinical Trial?

University of Utah

Lead Sponsor

Trials

1,169

Recruited

1,623,000+

Intermountain Health

Collaborator

Trials

1

Recruited

300+

Massachusetts General Hospital

Collaborator

Trials

3,066

Recruited

13,430,000+

References

1. United States pubmed.ncbi.nlm.nih.gov

Health literacy among cancer survivors: Results from the 2016 behavioral risk factor surveillance system survey. [2023]

2. United States pubmed.ncbi.nlm.nih.gov

Relationships Among Health Insurance Literacy, Financial Toxicity, and Sociodemographic Factors in Patients With Cancer. [2023]

3. Germany pubmed.ncbi.nlm.nih.gov

Health literacy among long-term survivors of breast cancer; exploring associated factors in a nationwide sample. [2022]

4. England pubmed.ncbi.nlm.nih.gov

Is Health Insurance Literacy Associated With Financial Hardship Among Cancer Survivors? Findings From a National Sample in the United States. [2020]

5. Ireland pubmed.ncbi.nlm.nih.gov

Preferences for patient-centered care among cancer survivors 5 years post-diagnosis. [2020]

6. England pubmed.ncbi.nlm.nih.gov

Comparison of Cancer-specific and General Health Literacy Assessments in an Educated Population: Correlations and Modifying Factors. [2018]

7. England pubmed.ncbi.nlm.nih.gov

HIAYA CHAT study protocol: a randomized controlled trial of a health insurance education intervention for newly diagnosed adolescent and young adult cancer patients. [2023]

8. Germany pubmed.ncbi.nlm.nih.gov

"I thought there would be more I understood": health insurance literacy among adolescent and young adult cancer survivors. [2023]